Jump to content
IndiaDivine.org

Correct use of patents

Rate this topic


Guest guest

Recommended Posts

<<So if one can effectively supplement yin or move blood with low

dose

chinese patents, how do we know? and despite names like liu wei di

huang

WAN, what was actually the standard for administration in ancient

china.

What is the standard now. And if low dose pills are effective for

these

conditions, are they being used that way in china? Why or why not? Is

there research to support their efficacy?

 

Oh yeah. I will stipulate that some people think such statistical

research

is without value or misguided. We will not debate that point any

further

as we will not debate the value of oral traditions. I value both to

some

degree. For those who don't, we will have to agree to disagree on

that

point. anyone who finds research based data offensive can always

delete

those posts. :-)

>>

 

In his booklet on safety of herbs, Giovanni Maciocia cites research

that the concentration of a drug in the blood can vary by a factor of

about 20, depending on the person's metabolism.

 

I have known very experienced oriental doctors prescribe decoctions

at the 'full Chinese dose', to quarter this dose. Prof. Wu Bo Ping

thought that accuracy of prescribing was a very importnat

determinant, and that if one was off the mark, one needed more herbs,

but if one had achieved an accurate diagnosis and prescribed

accordingly, half the standard Chinese dose per day sufficed.

 

In my own clinical experience, some people need larger doses, some

less - it also depends on what one is treating. I can't see that

finding suitable doses is much of a problem for an experienced

practitioner. It's like how much needle stimulation to give in

acupuncture - once one has enough experience, one will trust one's

judgement.

 

I would be very careful about waiting for research to 'answer' this

sort of question - it's entirely possible that standardisation would

be a mistake, for more than one of the reasons cited above.

 

Wainwright

Link to comment
Share on other sites

but what is small? below the phamrmological threshold or at the threshold. I

believe low threshold doses work, but slowly and unreliably. If we say below

threshold doses work, we need a mechanism.

>>>>I have seen some dr giving what would be considered the regular recommended

doses for pills ie, small balls about 30-60 day

aon

 

 

Link to comment
Share on other sites

At 3:54 PM +0000 11/24/03, wainwrightchurchill wrote:

>In my own clinical experience, some people need larger doses, some

>less - it also depends on what one is treating. I can't see that

>finding suitable doses is much of a problem for an experienced

>practitioner. It's like how much needle stimulation to give in

>acupuncture - once one has enough experience, one will trust one's

>judgement.

>

>I would be very careful about waiting for research to 'answer' this

>sort of question - it's entirely possible that standardisation would

>be a mistake, for more than one of the reasons cited above.

--

 

Wainwright,

 

You've raised the issue of what is researchable, and if we were to do

research, what sort of information would we be looking for. As you've

pointed out, dosing is a matter of judgement, and so would be almost

impossible to reduce to a set of fixed rules. Even in pharmaceutical

medicine this is not possible, and specialists are always finessing

dosage for individual patients. I think we can probably say that

there is a rather wide range of doses that will have at least some

effect in any given case, but to find the optimum dose for that

patient at any given time is always going to require judgement. More

experienced and well trained practitioners are more likely to get the

optimum result more often, but most practitioners are going to get

some result in most cases if they stay within a fairly broad range of

dosing, and their treatment strategy is appropriate.

 

Another factor to consider is that in Chinese herbal medicine,

treatment strategies are often used to achieve a short term goal,

within the context of a case that might take a long time to treat and

involve many different formulas. I think this level of complexity

does not lend itself to research studies, rather to well documented

case studies.

 

Rory

--

 

 

 

Link to comment
Share on other sites

<<Another factor to consider is that in Chinese herbal medicine,

treatment strategies are often used to achieve a short term goal,

within the context of a case that might take a long time to treat and

involve many different formulas. I think this level of complexity

does not lend itself to research studies, rather to well documented

case studies.

 

Rory>>

 

Rory,

That's a very good point. 'Many different formulas' probably should

include variants of one formula - technically, a modified formula is

a different formula.

 

Wainwright

Link to comment
Share on other sites

Wainwright,

 

Jiao Shu-De supports your statement and gives an example on Ten

Lectures of changes in dosage of Da Huang, Hou Po and Zhi Shi creates

three different formulas: Xia Cheng Qi Tang, Hou Po San Wu Tang and

Hou Po Da Huang Tang.

 

Fernando

 

 

, " wainwrightchurchill "

<w.churchill_1-@t...> wrote:

'Many different formulas' probably should

> include variants of one formula - technically, a modified formula

is

> a different formula.

>

>

Link to comment
Share on other sites

, " wainwrightchurchill " <

w.churchill_1-@t...> wrote:

 

>

> In his booklet on safety of herbs, Giovanni Maciocia cites research

> that the concentration of a drug in the blood can vary by a factor of

> about 20, depending on the person's metabolism.

 

source of that info, please. that seems very high.

 

 

>

> I have known very experienced oriental doctors prescribe decoctions

> at the 'full Chinese dose', to quarter this dose. Prof. Wu Bo Ping

> thought that accuracy of prescribing was a very importnat

> determinant, and that if one was off the mark, one needed more herbs,

> but if one had achieved an accurate diagnosis and prescribed

> accordingly, half the standard Chinese dose per day sufficed.

 

I think we agree here. I don't dispute giving herbs within their dose range to

be effective. So a formula prescribed at 90 grams might be no more effective

than another one at 30 grams and the latter might be better in some cases.

Both meet the pharmacological threshold, though. I have made this point is

my support for kanpo. The argument some are making is for much lower

doses, well below accepted pharmacological thresholds, like 2 grams per

day. this suggests another mode of action and I have never met a chinese

doc who was comfortable or experienced at this level of prescribing, though

Jim says otherwise. anyone else have chinese teachers who practiced this

way?

 

As for research, if one can determine drug dose ranges in large enough

groups, one can do the same with herbs. If you test 1000 people and only

300 respond to low doses, that's a placebo. Once the group gets large

enough, the individual variations can be factored out. Or at the very least,

one

should be able to prove whether low doses of herbs have ever effectively

treated any complaint. give low doses to 1000 people with IBS and see how

many get well. Try high doses. As for pattern taking precedence over

potency, that's just another unproven bias. In fact, double research on IBS

disproves this. In fact, most chinese research show excellent results

practicing allopathically. Again, believe it when I see it and the only way

I'll

ever see enough is in research since I can't personally live 1000 years and

treat all conditions. You are not suggesting that a modern healthcare system

be based upon blind allegiance to the ancestors, are you?

 

Link to comment
Share on other sites

, Rory Kerr <rory.kerr@w...>

wrote:

In F & S liu wei di huang wan is

> recommended as small pills at 9 gm tid.

 

that's my point. Will is suggesting not 9 g TID for yin xu (which would be 135

little black pills, BTW, but 8 pills TID, which is 1/2 g TID or 20 times less

than

the dose you mention). I know pills have historical and modern use, but at

this low a dose? that is the claim I would like to see grounded in either

history

or research. I really do not think that question has been answered or even

asked.

 

Link to comment
Share on other sites

, " wainwrightchurchill " <

w.churchill_1-@t...> wrote:

> <<Another factor to consider is that in Chinese herbal medicine,

> treatment strategies are often used to achieve a short term goal,

> within the context of a case that might take a long time to treat and

> involve many different formulas. I think this level of complexity

> does not lend itself to research studies, rather to well documented

> case studies.

 

actually it lends itself to both, IMO. A controlled study that is designed to

measure outcomes rather than micromanage therapies can demonstrate broad

and valid comparisons. Such a study would also validate the very style of CM

that we all practice and hold dear. Let me begin by saying that I believe Will

may be correct in this matter and I am motivated to see him proved right as it

would be of great benefit to our patients if he is.

 

So, for example:

 

Perimenopausal Nightsweating and hot flashes due to kidney yin and yang xu

 

Group 1 - receives individualized raw herb formulas from senior herbalists

with no restrictions on additional pattern diagnosis or herb selection or dosage

 

group 2 - receives patent medicines in any combination and dosage with no

restrictions on additional pattern diagnosis

 

group 3 - receives patent medicines in low dose form (8 pills TID of lanzhou

foci products or equivalent) with no restrictions on additional pattern

diagnosis

 

group 4 - receives patent medicines in low dose form (8 pills TID of lanzhou

foci products or equivalent) with no additional pattern diagnosis

 

group 5 - placebo

 

group 6 - nothing

 

and while we may have a broader definition of health and healing, the general

public, insurers, medical doctors and regulators do not. So I do not agree that

there is nothing to measure that would be of value here. We can evaluate

symptom relief the same way they do for hormones (they still are thought to

work for hot flashes, y'know). We can also measure hormone levels to see if

any changes occur (reports from China are that they do). This type of data

could be used to redirect HMOs to us as the try to figure out how to take care

of their middle-aged female insurees. I guess it depends who you talk to. My

father was a pharmacist and then at Merck. My step-grandfather was a

medical doctor at Lincoln Hospital in the bronx. This is the type of data they

want to see. My Dad is the age of many of the decisonmakers in the various

groups referred to above, so I think those in power are definitely looking for

this kind of old-fashioned stuff.

 

Just imagine if it was shown that a 2 dollar per week supply of liu wei di

huang wan or xue fu zhu yu tang could address many of the most devastating

complaints of our era (in combination with good diet and exercise, of course).

Or that even a $100 per month supply of herbs could do it. either way. This

type of experiment would not tie the hands of practitioners (since groups 1-4

would probably all work well enough to justify insurance or MD referral - but

who needs insurance for $8 a month of herbs - that's less than your co-pay - I

am not being flippant here). And useful " data " could be easily collected. why

would such a study be invalid or detrimental or useless? Such a study would

probably cause a dramatic shift in use of CM overnight, much moreso than any

goodwill and word of mouth. Currently, less than 1% of patients for

acupuncture come for GYN complaints. We could turn that into 25% of all

american females with a study like this.

 

I think the point that may be missed is that politicians and medical doctors

and HMO execs are busy people who want to be fed a big picture with solid

numbers that is easy to understand. None of these folks are experts in

research. If the numbers are simple and generally considered valid, they will

make our case. No one will be prevented from doing any nuance they want in

private tx. We don't need to use the long narrative case to make our point. In

fact, no one wants to hear it. But we can certainly use individualized case

studies to collect group data. I believe this is considered the cutting edge in

medical research - outcomes studies.

 

I think its a shame we cannot even agree on this basic point. I am actually

shocked that there is a contingent of our profession that does not see the

immense social and political value in such research. I would be lying if I

thought the value was clinical. We do fine without it. But I think we limp

along each day we continue to debate whether we should do research instead

of just doing it. It is my goal that CHA will someday play a role in this. I

know

enough members feel the same as me. All we need is someone to write a

grant. Anyone game? There's definitely some money in it for the lead clinician

:-).

 

Link to comment
Share on other sites

, " " wrote:

It is my goal that CHA will someday play a role in this. I know

> enough members feel the same as me. All we need is someone to

write a grant. Anyone game? There's definitely some money in it for

the lead clinician :-).

 

:

 

Wouldn't any herb company, say Blue Poppy for instance, be willing

to donate herbal formulas for this? Think of the publicity.

 

 

Jim Ramholz

Link to comment
Share on other sites

> In his booklet on safety of herbs, Giovanni Maciocia cites research

> that the concentration of a drug in the blood can vary by a factor

of

> about 20, depending on the person's metabolism.

 

source of that info, please. that seems very high. Todd>>

 

Having read Giovanni's booklet 'Safety of Chinese Herbal Medicine'

some years ago, I quoted this figure incorrectly. It seems that a 5-

fold variation in plasma concentration is generally accepted, but

some say that individual variations vary from 4-fold to 40-fold

(Cohen JS, Preventing Adverse Drug Reactions before they occur,

Medscape Pharmacology, Medscape.com, 1999.)

Link to comment
Share on other sites

<<As for research, if one can determine drug dose ranges in large

enough

groups, one can do the same with herbs. If you test 1000 people and

only

300 respond to low doses, that's a placebo. Once the group gets large

enough, the individual variations can be factored out. Or at the very

least, one

should be able to prove whether low doses of herbs have ever

effectively

treated any complaint. give low doses to 1000 people with IBS and see

how

many get well. Try high doses. As for pattern taking precedence over

potency, that's just another unproven bias. In fact, double research

on IBS

disproves this. In fact, most chinese research show excellent results

practicing allopathically. Again, believe it when I see it and the

only way I'll

ever see enough is in research since I can't personally live 1000

years and

treat all conditions. You are not suggesting that a modern healthcare

system

be based upon blind allegiance to the ancestors, are you? Todd>>

 

 

It might be possible to conduct general research reducing the dosage

of herbs to a point at which the overall rate of efficacy was equal

or less than a placebo. While theoretically possible, it seems to me

that such research is many steps away from where research is at the

momunt, or is likely to be within the foreseeable future. It begs

many issues, such as the theoretical principles for carrying out such

research.

 

As for small doses, I once saw a TV program about the pesticide

Lindane, where a toxicologist argued that, 'if you want to get the

most bangs for your bucks' (his expression), rather than give a

person a relatively high dosage of a toxin for a short amount of

time, more damage will be done if you give the same total amount in a

lower dose over a greater period of time. Of course, this doesn't

apply under certain circumstances, e.g. if the high dose kills the

person outright.

 

Wainwright

Link to comment
Share on other sites

This is the exact kind of thinking that IMO is needed from our

profession. Now that the unwanted chatter from overly-expressive

overly-anti-western member(s) have been chopped down, maybe we can

come to some middle ground... Since research is necessary, and stats

go along with any research, let's discuss the best way to utilize

such information to best propel our profession. (BTW) I 100% agree

that having some research, such as below, in no way binds our

treatments in the real life clinic, this is just paranoia.

 

-

 

, " "

wrote:

> , " wainwrightchurchill " <

> w.churchill_1-@t...> wrote:

> > <<Another factor to consider is that in Chinese herbal medicine,

> > treatment strategies are often used to achieve a short term goal,

> > within the context of a case that might take a long time to treat

and

> > involve many different formulas. I think this level of complexity

> > does not lend itself to research studies, rather to well

documented

> > case studies.

>

> actually it lends itself to both, IMO. A controlled study that is

designed to

> measure outcomes rather than micromanage therapies can demonstrate

broad

> and valid comparisons. Such a study would also validate the very

style of CM

> that we all practice and hold dear. Let me begin by saying that I

believe Will

> may be correct in this matter and I am motivated to see him proved

right as it

> would be of great benefit to our patients if he is.

>

> So, for example:

>

> Perimenopausal Nightsweating and hot flashes due to kidney yin and

yang xu

>

> Group 1 - receives individualized raw herb formulas from senior

herbalists

> with no restrictions on additional pattern diagnosis or herb

selection or dosage

>

> group 2 - receives patent medicines in any combination and dosage

with no

> restrictions on additional pattern diagnosis

>

> group 3 - receives patent medicines in low dose form (8 pills TID

of lanzhou

> foci products or equivalent) with no restrictions on additional

pattern

> diagnosis

>

> group 4 - receives patent medicines in low dose form (8 pills TID

of lanzhou

> foci products or equivalent) with no additional pattern diagnosis

>

> group 5 - placebo

>

> group 6 - nothing

>

> and while we may have a broader definition of health and healing,

the general

> public, insurers, medical doctors and regulators do not. So I do

not agree that

> there is nothing to measure that would be of value here. We can

evaluate

> symptom relief the same way they do for hormones (they still are

thought to

> work for hot flashes, y'know). We can also measure hormone levels

to see if

> any changes occur (reports from China are that they do). This type

of data

> could be used to redirect HMOs to us as the try to figure out how

to take care

> of their middle-aged female insurees. I guess it depends who you

talk to. My

> father was a pharmacist and then at Merck. My step-grandfather was

a

> medical doctor at Lincoln Hospital in the bronx. This is the type

of data they

> want to see. My Dad is the age of many of the decisonmakers in the

various

> groups referred to above, so I think those in power are definitely

looking for

> this kind of old-fashioned stuff.

>

> Just imagine if it was shown that a 2 dollar per week supply of liu

wei di

> huang wan or xue fu zhu yu tang could address many of the most

devastating

> complaints of our era (in combination with good diet and exercise,

of course).

> Or that even a $100 per month supply of herbs could do it. either

way. This

> type of experiment would not tie the hands of practitioners (since

groups 1-4

> would probably all work well enough to justify insurance or MD

referral - but

> who needs insurance for $8 a month of herbs - that's less than your

co-pay - I

> am not being flippant here). And useful " data " could be easily

collected. why

> would such a study be invalid or detrimental or useless? Such a

study would

> probably cause a dramatic shift in use of CM overnight, much moreso

than any

> goodwill and word of mouth. Currently, less than 1% of patients

for

> acupuncture come for GYN complaints. We could turn that into 25%

of all

> american females with a study like this.

>

> I think the point that may be missed is that politicians and

medical doctors

> and HMO execs are busy people who want to be fed a big picture with

solid

> numbers that is easy to understand. None of these folks are

experts in

> research. If the numbers are simple and generally considered

valid, they will

> make our case. No one will be prevented from doing any nuance they

want in

> private tx. We don't need to use the long narrative case to make

our point. In

> fact, no one wants to hear it. But we can certainly use

individualized case

> studies to collect group data. I believe this is considered the

cutting edge in

> medical research - outcomes studies.

>

> I think its a shame we cannot even agree on this basic point. I am

actually

> shocked that there is a contingent of our profession that does not

see the

> immense social and political value in such research. I would be

lying if I

> thought the value was clinical. We do fine without it. But I

think we limp

> along each day we continue to debate whether we should do research

instead

> of just doing it. It is my goal that CHA will someday play a role

in this. I know

> enough members feel the same as me. All we need is someone to

write a

> grant. Anyone game? There's definitely some money in it for the

lead clinician

> :-).

>

 

Link to comment
Share on other sites

" Will is suggesting not 9 g TID for yin xu (which would be 135 little black

pills, BTW, but 8 pills TID, which is 1/2 g TID or 20 times

less than > the dose you mention). I know pills have historical and modern use,

but at this low a dose? that is the claim I would like

to see grounded in either history or research. I really do not think that

question has been answered or even

asked. "

 

 

 

I think an important question to ask is if Will routinely prescribes this dose

along with acupuncture. If so, then who's to say whether

his outcomes are due to the herbs, to acupuncture, or to some combination of the

two?

 

Bob

Link to comment
Share on other sites

 

 

I don't know anything about grant-writing. However, let me make a counter

proposal. I would be willing to donate enough Ultimate

Immortals to do a comparison study on dose-based efficacy. Six wings would be

very unweildy and hard to accomplish. Having been

involved in a large three wing RCT with the NIH, I can tell you you'd have

problems enrolling enough patients to make the study valid. I

would propose a two wing study. One wing with perimenopausal night sweats could

receive Ultimate Immortals at a higher dose and

another group could receive it at a much lower dose equivalent to the 8 pills

TID recommended for Lanzhou Pai ready-made pills. Then

there could be a third comparison (based on published literature) to the already

established outcomes within Western medicine for

this same complaint. This study would help solve the argument (within our

profession) about the role of dosage in the use of

rady-made Chinese herbal medicines, and it might help popularize Chinese

medicine in the larger health care marketplace.

 

Any takers?

 

Bob

Link to comment
Share on other sites

At 4:03 AM +0000 11/25/03, wrote:

>Perimenopausal Nightsweating and hot flashes due to kidney yin and yang xu

>

>Group 1 - receives individualized raw herb formulas from senior herbalists

>with no restrictions on additional pattern diagnosis or herb

>selection or dosage

>

>group 2 - receives patent medicines in any combination and dosage with no

>restrictions on additional pattern diagnosis

>

>group 3 - receives patent medicines in low dose form (8 pills TID of lanzhou

>foci products or equivalent) with no restrictions on additional pattern

>diagnosis

>

>group 4 - receives patent medicines in low dose form (8 pills TID of lanzhou

>foci products or equivalent) with no additional pattern diagnosis

>

>group 5 - placebo

>

>group 6 - nothing

==

 

 

 

I'm interested in why you would do a study this way. If our objective

is to show the rest of the world that CM has an effective treatment

for menopausal hot flashes, it seems to me that we would want to

study one treatment type, ie our professional standard, individual

prescription, rather than four. Your method would tell us which

methods of the four was more or less effective, whereas all we need

to show is that one method is effective. No?

 

Rory

--

 

 

 

Link to comment
Share on other sites

At 4:03 AM +0000 11/25/03, wrote:

>I think its a shame we cannot even agree on this basic point. I am actually

>shocked that there is a contingent of our profession that does not see the

>immense social and political value in such research.

--

 

 

 

I think it is an accurate generalization to say that on any give

topic, any group of people is going to divide into at least two

groups with differing if not opposing views. So don't be shocked!

 

For myself, I'm persuaded that although I believe research should be

an important activity in our profession, we definitely have an

interest in controlling the type of research to avoid

biomedicalization, and in speaking out when research is used to

plunder or discredit our resources. I think we can do this by

becoming well educated and engaged, not by rationalizing isolationism.

 

Rory

--

 

 

 

Link to comment
Share on other sites

At 1:20 AM +0000 11/25/03, wrote:

>Again, believe it when I see it and the only way I'll

>ever see enough is in research since I can't personally live 1000 years and

>treat all conditions.

--

 

 

 

I don't know whether you have done this, but you can get a long way

by spending six months in clinic in a Chinese teaching hospital. You

would probably see at least 5000 patient visits during that time, and

a very wide range of diseases conditions.

 

Rory

--

 

 

 

Link to comment
Share on other sites

the role of dosage in the use of

rady-made Chinese herbal medicines, and it might help popularize Chinese

medicine in the larger health care marketplace.

 

Any takers?

 

>>>IT would be better if there is also a group receiving placebo, but if cannot

find enough patients than a third party should dispense the herbs so that no one

knows who is getting what

alon

 

 

Link to comment
Share on other sites

For myself, I'm persuaded that although I believe research should be

an important activity in our profession, we definitely have an

interest in controlling the type of research to avoid

biomedicalization, and in speaking out when research is used to

plunder or discredit our resources. I think we can do this by

becoming well educated and engaged, not by rationalizing isolationism.

>>>I totally agree

alon

 

 

Link to comment
Share on other sites

Bob Flaws wrote:

>This study would help solve the argument (within our profession)

>about the role of dosage in the use of rady-made Chinese herbal

>medicines, and it might help popularize Chinese medicine in the

>larger health care marketplace.

>

>Any takers?

--

 

Bob,

 

At the risk of repeating myself, I think these two objectives should

be kept apart, and that we should focus on one objective in any given

study. If we want to convince the world, of the effectiveness of CM

in a given condition, we should do a study of what we think is our

optimal therapy, individual prescription. If we want to compare CM

therapies, then design a study with that objective. When both studies

are complete, they can be compared, assuming they have the same

standards of randomization etc. Of course, there's no reason why two

different groups could not be doing the two studies at the same time,

in different places.

 

BTW, I know you do a lot of Chinese journal reading. Has this ground

not already been covered to some extent with respect to menopause and

CM?

 

Rory

--

 

 

 

Link to comment
Share on other sites

, Rory Kerr <rory.kerr@w...>

wrote:

 

>

>

>

> I'm interested in why you would do a study this way. If our objective

> is to show the rest of the world that CM has an effective treatment

> for menopausal hot flashes, it seems to me that we would want to

> study one treatment type, ie our professional standard, individual

> prescription, rather than four. Your method would tell us which

> methods of the four was more or less effective, whereas all we need

> to show is that one method is effective. No?

 

 

there is more than one goal here, one of which is to determine the most cost

effective approach to CM. I think the issue of what form of CM works best is

just as important as whether CM works at all. If it is easy enough to ascertain

both, why not. Rember my original idea was merely to study patents vs. raw.

It was only an afterthought that the implications would be beneficial for CM as

a whole regardless of the outcome. However Bob Flaws's proposal is probably

more reasonable and would settle the dosage issue in many people's minds

(though many others would stubbornly cling to prior ideas anyway).

 

Link to comment
Share on other sites

> >>>IT would be better if there is also a group receiving placebo, but if

cannot find enough patients than a third party should dispense

the herbs so that no one knows who is getting what

> alon

 

Agreed.

 

Bob

Link to comment
Share on other sites

, Rory Kerr <rory.kerr@w...>

wrote:

 

> I don't know whether you have done this, but you can get a long way

> by spending six months in clinic in a Chinese teaching hospital. You

> would probably see at least 5000 patient visits during that time, and

 

 

rory

 

I've heard mixed reviews about such a rotation as it applies to my needs.

Perhaps others who have worked in these hospitals can address these various

issues that have been raised with me by many travelers to China over the

years. As usual, I speak from my experiences and conversations here in the

US and my words in no way reflect any actual knowledge of what goes on on

the ground in china.

 

1. the patients are often not followed up over time and any reported cures

may be transient

 

2. the time devoted to each patient is not adequate to learn very much about

any given case. the thought process of the physician is usually not explained

in any detail.

 

3. there is a tendency to focus on sx relief and detailed exploration of

complaints is absent.

 

4. there is a tendency to type patients rather than fully pattern them (as

Scheid explains it).

 

Link to comment
Share on other sites

BTW, I know you do a lot of Chinese journal reading. Has this ground

not already been covered to some extent with respect to menopause and

CM?

>>>At this point there is no good and positive study done in US on menopause in

any form of herbs

Alon

 

 

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...